The largest database of trusted experimental protocols

11 protocols using anti v5 agarose

1

Purification of Replication Complexes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wild-type Mcm2–7/Cdt1 and ORC complexes were purified as described previously (Kang et al., 2014 (link)). Wild-type Cdc6 was purified as described in Frigola et al. (2013) (link). DDK, S-CDK, Sld3/7, Cdc45, Sld2, Dpb11, GINS, Mcm10, Polymerase epsilon, Polymerase alpha/primase, Polymerase delta, RPA, Ctf4, RFC, PCNA, Mrc1, Csm3-Tof1, and Topo II were purified as described in Lõoke et al. (2017) (link). Mutant Mcm2-7/Cdt1 complexes were purified as described in Kang et al. (2014) (link) with the following modifications. For each Mcm2-7 mutant complex, the corresponding wild-type proteins were epitope-tagged with either c-Myc or V5. In the strains expressing the Mcm2 Δ2–177 and Mcm6 Δ2–105, the wild-type MCM2 and MCM6 genes were tagged with c-Myc, to allow the endogenous 13Myc-tagged Mcm2 or Mcm6 subunits to be depleted by incubating with anti-c-Myc agarose (Sigma) before applying the Mcm2-7 mutant complex to a Superdex 200 gel filtration column. In strains expressing mutant Mcm4 protein, the wild-type MCM4 gene was tagged with V5. Mcm2-7 complexes containing the endogenous V5-tagged Mcm4 subunits were depleted by incubating with anti-V5 agarose (Sigma) before application to a Superdex 200 gel filtration column. Yeast strains and plasmids used are listed in Supplementary file 1 - tables 2 and 3, respectively.
+ Open protocol
+ Expand
2

Investigating Herpes Glycoprotein Complexes

Check if the same lab product or an alternative is used in the 5 most similar protocols
CHO-DSP1 cells were transfected as described in the previous section with pCAGGS-gB vectors carrying the N-terminal mutations, pME18s-gH[V5] and pCDNA3.1-gL (1.6μg of each vector). To determine the specificity of the V5 immunoprecipitation of the gB/gH-gL complex, CHO-DSP1 cells were transfected pCAGGS-gB, pCDNA3.1-gL, pME18s-gH[WT] or pME18s-gH[V5], and the previously well characterized pBud-gE/gI vector [36 (link)] (1.5μg of each vector). At 24 hours post transfection cells were lysed with glycoprotein lysis buffer and snap frozen in liquid nitrogen and stored at -20°C. The gB/gH-gL complexes were immunoprecipitated with anti-V5 agarose (Sigma). Wash steps, protein elution and SDS-PAGE were performed as outlined in the previous section. Western blots were performed using either mouse anti-V5 tag (Bio-Rad), 746–868 rabbit poly clonal IgG, mAb 93k or mouse anti-gE (Millipore). The anti-gE mAb is very sensitive and can detect low concentrations of gE [36 (link),80 (link)–82 (link)], critical for demonstrating the specificity of the gB/gH-gL immunoprecipitation.
+ Open protocol
+ Expand
3

Protein-protein Interaction Identification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Expression plasmids were transfected into HEK293, OVCAR3, or MCF7 cells using Lipofectamine 2000 (Invitrogen). Cells were harvested 24 hr post-transfection for co-immunoprecipitation experiments. Cells were lysed in lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 1% NP40 supplemented with protease inhibitor cocktail (Thermo Scientific)). Lysates were then incubated with either anti-V5 agarose (Sigma, St. Louis, MO), or anti-FLAG M2 affinity gel (Sigma, St. Louis, MO). After five washes (3 times with lysis buffer and 2 times with TBS) precipitates were resuspended in Laemmli sample buffer containing 5% β-mercaptoethanol.
+ Open protocol
+ Expand
4

Immunoprecipitation of gB/gH-gL Complexes

Check if the same lab product or an alternative is used in the 5 most similar protocols
CHO-DSP1 cells were transfected as described in the previous section with pCAGGS-gB vectors carrying the DIV mutations, pME18s-gH[V5] and pCDNA3.1-gL (1.6 µg of each vector). At 24 h post transfection cells were lysed with glycoprotein lysis buffer and snap frozen in liquid nitrogen and stored at −20 °C. The gB/gH-gL complexes were immunoprecipitated with anti-V5 agarose (Sigma). Wash steps, protein elution, and SDS–PAGE were performed as outlined in the previous section. Western blots were performed using either mouse anti-V5 tag (Bio-Rad), 746–868 rabbit poly clonal IgG, or mAb 93k.
+ Open protocol
+ Expand
5

Immunoprecipitation of Tagged Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flag- or V5-tagged proteins were immunoprecipitated using anti-Flag M2 agarose (Sigma-Aldrich, Cat# A2220) or anti-V5 agarose (Sigma-Aldrich, Cat# A 7345), according to manufacturer’s instructions.
+ Open protocol
+ Expand
6

Affinity Purification of Protein Complexes

Check if the same lab product or an alternative is used in the 5 most similar protocols
U2OS and/or HEK293T cells were treated with ice-cold lysis buffer (PBS, 0.5% NP-40, 1 mM PMSF and a protease inhibitor cocktail mix) and the extract was centrifuged for 10 min at 20 × 103 g at 4°C. Concentration of the cytoplasmic extract was determined using a Bio-Rad protein assay (Bio-Rad Laboratories, Nazareth Eke, Belgium) according to the manufacturers’ prescriptions. Subsequently 0.5 mg of cytoplasmic extract was incubated with 2–5 μg recombinant V5-tagged nanobody or 2–5 μg lgG antibody of interest for 1–2 h at 4°C. The former step was skipped when working with stable nanobody-expressing U2OS cell lines. Afterward, 15 μl anti-V5 agarose (Sigma) or proteinG sepharose (GE Healthcare) was added to the sample and incubated for 1–2 h at 4°C. The beads were washed with lysis buffer, boiled for 5 min in Laemmli sample buffer and proteins were fractionated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE). Western blotting was performed as previously described (20 (link)).
+ Open protocol
+ Expand
7

Immunoprecipitation of EMRE Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293 cells (EMRE KO, EMRE KO + QN6 EMRE-V5 and EMRE KO + wild-type EMRE-V5) were grown to confluency in 150 mm plates. Cells were washed twice with PBS and lysed with 1 ml cold lysis buffer (50 mM HEPES-KOH pH 7.4, 150 mM NaCl, 0.2% n-dodecyl-β-D-maltoside, 0.5 mM EGTA, 0.3 mM CaCl2, one Complete protease inhibitor tablet (Roche) per 30 ml lysis buffer). Cells were lysed at 4°C for 30 min and centrifuged at 16,000 × g. Cleared lysates were diluted to normalize for protein concentration. Appropriate volumes of lysates were added, corrected for expression levels based on western blotting and densitometric analysis. Anti-V5 Agarose (30 μl; Sigma #A 7345) was added to diluted lysates and rocked 16 hr at 4°C. Beads were washed with 1 ml PBS 3x and boiled in 90 μl 2x SDS sample buffer. 20 μl of each immunoprecipitate and 30 μg of total cell lysates were loaded on Tris-Glycine gels for Western Blotting. To maintain a constant range [Ca2+] in lysis and wash buffers, CaCl2 and EGTA were added to buffers according to http://maxchelatorStanford.edu/CaEGTA-TS.htm. In addition, [Ca2+] in each preparation was measured with Fura-2. Solutions contained 150–450 nM free Ca2+.
+ Open protocol
+ Expand
8

Oligonucleosome Assembly and Protamine Eviction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Oligonucleosome assembly with S-190 extract and purified recombinant system was performed exactly as described (Fyodorov and Levenstein 2002 ; Fyodorov and Kadonaga 2003 (link)). For protamine eviction analyses, MSC substrate (equivalent to 20 μg of plasmid DNA) was treated with 4 mL of S-190 extract, fractionated by sucrose gradient sedimentation, and analyzed by anti-V5 Western blotting. Alternatively, protamines were evicted from MSC by incubating 0.47 pmol of substrate (∼1 μg of DNA) with >20-fold molar excess of recombinant NAP-1, NLP, Nph, and TAP/p32, and the reactions were fractionated on gravity-flow size exclusion columns. See the Supplemental Material for reaction conditions and details of analyses.
For purification of putative protamine chaperones, sucrose gradient fractions that contained V5-immunoreactive material were pooled and immunoprecipitated with anti-V5-agarose (Sigma).
+ Open protocol
+ Expand
9

Akirin Protein Immunoprecipitation in E. coli-Treated Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were treated for the indicated times with heat-killed E. coli (40:1) at 25°C. The cells were harvested, washed in PBS, and lysed in 500 μl of buffer containing 20 mM Tris–HCl, pH 7.5, 150 mM NaCl, 10% glycerol, 2 mM EDTA, 1 mM DTT, 1% NP-40, phosphatase inhibitor cocktail (Roche), and complete protease inhibitor cocktail (Roche). Immunoprecipitations were performed overnight at 4°C with rabbit polyclonal anti-Akirin antibody coupled with Dynabeads Protein G (Invitrogen), anti-V5 agarose (Sigma), or anti-Flag agarose (Sigma). Proteins from total cell lysates and immunoprecipitates were resolved by SDS-PAGE and detected by Western blotting using anti-V5 HRP (Invitrogen), anti-Akirin, anti-Flag HRP (Sigma), anti-Bap60 (gift from Susumu Hirose), anti-Relish (gift from Tony Ip), and anti-β-actin antibodies (BD Transduction Laboratories).
+ Open protocol
+ Expand
10

Immunoprecipitation of Flag- and HA-tagged Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
The process of Immunoprecipitation was previously described44 (link). Briefly, Xenopus embryo lysates were prepared with ice-cold TNSG buffer (20 mM Tris–HCl pH 7.5, 137 mM NaCl and 1% NP-40). IPs were performed for 4 h with 25 embryo equivalent extracts using monoclonal Anti-V5-agarose (Sigma-Aldrich). Western blot analysis was performed using anti-Flag–horseradish peroxidase (HRP)-conjugated (1:5,000, Sigma-Aldrich), anti-HA–HRP-conjugated (1:5,000, Sigma-Aldrich) anti-V5–HRP-conjugated (1:5,000, Sigma-Aldrich), anti-Phospho-p44/42 MAPK (Erk1/2) (Cell Signaling Technology), and anti-p44/42 MAPK (Erk1/2) (Cell Signaling Technology) antibodies.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!